About Neurobiogen Corporation

Business Strategies

Neurobiogen's longer term business strategies are :

	to be an international leader in its core research areas
	to take the in-house development of each of its compounds to as advanced a state of development as it believes is appropriate in order to enhance the commercial opportunities available to the Company in respect of each compound
	to negotiate collaborations with leading pharmaceutical companies, where the Company believes that the development and/or marketing of its lead compounds would be optimized by collaboration with our partners, whether it be during pre-clinical or clinical development of the compound.
	to maintain the commercial rights for its products in North America with the possibility of expanding these primary markets to Europe and Asia Pacific countries.

Joint venture

The Company business model is based on adding value to drug candidates by generating compelling clinical data and creating a strong regulatory position and then out-licensing the product to a partner for remaining development, launch, and marketing.

Through this strategy, Neurobiogen aims to achieve two main objectives. First, a long term collaboration relationship with our partners that yield mutually positive return of investment from the joint venture. Second, we aim to build up our capabilities in the areas of drug development, manufacturing of compounds on a larger scale for extended clinical trials and, in the long term, marketing and sales of our pharmaceutical products.

For further information in research collaboration or joint venture, please contact our Business Development Department at info@neurobiogen.com or complete the Online Contact Form.

[Home] [About Us] [Diseases] [Research] [Products] [Collaboration] [Joint Venture] [Contact]